CRSP
CRSP
NASDAQ · Biotechnology

Crispr Therapeutics Ag

$58.33
+1.77 (+3.13%)
As of Sep 21, 8:45 PM ET ·
Analyst Consensus
Buy
28
Analysts
High
Coverage
Buy 17 61%
Hold 11 39%
Sell 0 0%
Price Target
Analyst Price Target +90.4% upside
Low Target $83.97
Average Target $111.08
High Target $162.31
Current Price $58.33
Current
$58.33
Target
$111.08
$83.97 $111.08 avg $162.31
Scenario Analysis
Bear Case
$83.97
44.0%
Low target
Base Case
$111.08
+90.4%
Avg target
Bull Case
$162.31
+178.3%
High target
Risk/Reward
4.1x
Highly favorable
Price in Context
52-Week High
$78.48
-25.7% from high
52-Week Low
$44.12
+32.2% from low
50-Day SMA
$54.19
+7.6% vs SMA
200-Day SMA
$54.12
+7.8% vs SMA
RSI (14)
52.8
Neutral
Target vs 52W High
$111.08
+41.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.7%
AMGN
Amgen Inc
Hold 43 47% $190.87 -51.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +139.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.3%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.3%
MRNA
Moderna Inc
Hold 30 37% $149.45 -13.8%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -61.5%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -41.0%